No significant increase in the amount of CD8+ T cells was observed at any of the time points or infection doses (day 3: 2.62 ± 0.38% (low dose); 3.34 ± 1.07% (high dose); day 6: 2.54 ± 0.74% (low dose); 3.65 ± 1.81% (high dose); day 9: 4.29 ± 1.63% (low dose); 3.52 ± 1.47% (high dose), Figure 2D) compared to uninfected controls. Here, CD8A is linked to infection.